ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients ...

ALISO VIEJO, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients ...

On November 29, 2024, RxSight, Inc. filed a notice of data breach with the Attorney General of Montana after discovering that an unauthorized party accessed an employee’s email account.

9 analysts have expressed a variety of opinions on RxSight (NASDAQ:RXST) over the past quarter, offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...

BofA lowered the firm’s price target on RxSight (RXST) to $36 from $60 and keeps a Buy rating on the shares. Shares are down 61% since hitting all-time highs in June 2024 as the stock re-rated ...

Stifel lowered the firm’s price target on RxSight (RXST) to $28 from $33 and keeps a Hold rating on the shares. While telling investors that RxSight has become a near-term “show-me” story ...

In the last three months, 11 analysts have published ratings on RxSight RXST, offering a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings ...

Last week, you might have seen that RxSight, Inc. (NASDAQ:RXST) released its annual result to the market. The early response was not positive, with shares down 7.0% to US$28.21 in the past week.